StockData
Turn Therapeutics Inc. logo

Turn Therapeutics Inc. (TTRX) income statement

TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30
$8.89+0.34 (+3.98%)

Close on Nov 18, 2026Market cap $264.82MP/E –Yield –

Turn Therapeutics Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-141.7%

Financial strength

Current ratio
3.19
Debt to equity
1.09
Debt to assets
37.8%
Cash to current liabilities
271.2%

Valuation

P/E ratio
–
Price to sales
–
Price to book
46.52
Dividend yield
–

See a number that looks wrong?